van der Weiden R M, Noort W A, Naaktgeboren N, Helmerhorst F M, Keirse M J
Department of Obstetrics, Gynecology and Reproduction, Leiden University Hospital, The Netherlands.
Fertil Steril. 1994 Dec;62(6):1217-20. doi: 10.1016/s0015-0282(16)57188-x.
To determine prostanoid levels (prostaglandin E2, prostaglandin F2 alpha, 6-keto-prostaglandin F1 alpha, and thromboxane B2 [TXB2]) in embryo culture medium containing inactivated maternal serum and their correlation with the clinical outcome of IVF-ET.
Prostanoid levels were measured in blank control medium and in medium containing an embryo or nonfertilized oocyte with a high-pressure liquid chromatography (HPLC-RIA) method. Comparisons of HPLC-RIA, Seppak C18-RIA, and RIA directly in the medium demonstrated identical results for TXB2, allowing the use of direct RIA in the large investigation of 129 media.
Leiden University Hospital, The Netherlands.
Patients with (n = 12) and without (n = 15) an ongoing pregnancy after IVF-ET.
Prostanoid levels in embryo culture medium and relationship between prostanoid levels and successful implantation.
Thromboxane B2 is the only prostanoid consistently found in these media. In both groups there was no difference in TXB2 levels between control media, media containing a nonfertilized oocyte, and media containing an embryo. There was no difference in TXB2 levels between media that had harbored the beginning of a successful pregnancy and those that had not produced a pregnancy.
Thromboxane B2 in the embryo culture medium originates from maternal serum and bears no relationship with the likelihood of fertilization and implantation.
测定含有灭活母体血清的胚胎培养基中类前列腺素水平(前列腺素E2、前列腺素F2α、6-酮-前列腺素F1α和血栓素B2 [TXB2])及其与体外受精-胚胎移植(IVF-ET)临床结局的相关性。
采用高压液相色谱法(HPLC-RIA)测定空白对照培养基以及含有胚胎或未受精卵母细胞的培养基中的类前列腺素水平。HPLC-RIA、SepPak C18-RIA和直接在培养基中进行的放射免疫分析(RIA)对TXB2的检测结果相同,这使得在对129份培养基进行的大规模研究中可以使用直接RIA法。
荷兰莱顿大学医院。
IVF-ET后有(n = 12)和无(n = 15)持续妊娠的患者。
胚胎培养基中的类前列腺素水平以及类前列腺素水平与成功着床之间的关系。
血栓素B2是这些培养基中唯一始终能检测到的类前列腺素。在两组中,对照培养基、含有未受精卵母细胞的培养基和含有胚胎的培养基之间TXB2水平无差异。成功妊娠开始的培养基与未妊娠培养基之间TXB2水平无差异。
胚胎培养基中的血栓素B2源自母体血清,与受精和着床的可能性无关。